UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 65

Sortiert nach

Can ChatGPT Correct Code Based on Logical Steps?

2023 30th Asia-Pacific Software Engineering Conference (APSEC), 2023, p.653-654

2023

Link zum Volltext
IEEE_Xplore

Is neural machine translation approach accurate enough for coding assistance?

Proceedings of the 1st ACM SIGPLAN International Workshop on Beyond Code: No Code, 2021, p.23-28

2021

Link zum Volltext

Verfügbarkeit prüfen

New-onset Type 1 Diabetes after COVID-19 mRNA Vaccination

Internal Medicine, 2022/04/15, Vol.61(8), pp.1197-1200

2022

Link zum Volltext

Verfügbarkeit prüfen

New‐onset fulminant type 1 diabetes after severe acute respiratory syndrome coronavirus 2 vaccination: A case report

Journal of diabetes investigation, 2022-07, Vol.13 (7), p.1286-1289

2022

Link zum Volltext

Verfügbarkeit prüfen

Positive association between proinsulin and fatty liver index in people with type 2 diabetes

Endocrine Journal, 2024, Vol.71(2), pp.193-197

2024

Link zum Volltext

Verfügbarkeit prüfen

Regulation of c‐MYC transcriptional activity by transforming growth factor‐beta 1‐stimulated clone 22

Cancer science, 2018-02, Vol.109 (2), p.395-402

2018

Link zum Volltext

Verfügbarkeit prüfen

A chemogenetic platform for controlling plasma membrane signaling and synthetic signal oscillation

Cell chemical biology, 2022-09, Vol.29 (9), p.1446-1464.e10

2022

Link zum Volltext

Verfügbarkeit prüfen

History of the G Protein–Coupled Receptor (GPCR) Assays From Traditional to a State-of-the-Art Biosensor Assay

Journal of Pharmacological Sciences, 2014/12/20, Vol.126(4), pp.302-309

2014

Link zum Volltext

Verfügbarkeit prüfen

Dynamic changes in endoplasmic reticulum morphology and its contact with the plasma membrane in motor neurons in response to nerve injury

Cell and tissue research, 2024-04, Vol.396 (1), p.71-84

2024

Link zum Volltext

Verfügbarkeit prüfen

Role of adiponectin in the relationship between visceral adiposity and fibroblast growth factor 23 in non-diabetic men with normal kidney function

Endocrine Journal, 2022, Vol.69(2), pp.121-129

2022

Link zum Volltext

Verfügbarkeit prüfen

Successful management of a patient with active Cushing’s disease complicated with coronavirus disease 2019 (COVID-19) pneumonia

Endocrine Journal, 2021, Vol.68(4), pp.477-484

2021

Link zum Volltext

Verfügbarkeit prüfen

Do the benefits of sodium-glucose cotransporter 2 inhibitors exceed the risks in patients with type 1 diabetes?

Endocrine Journal, 2022, Vol.69(5), pp.495-509

2022

Link zum Volltext

Verfügbarkeit prüfen

786-P: Effects of Switching from Liraglutide or Dulaglutide to Subcutaneous Semaglutide on Metabolic Parameters in Older People with Type 2 Diabetes Mellitus—SWITCH-SEMA1 Subgroup Analysis

Diabetes (New York, N.Y.), 2023-06, Vol.72 (Supplement_1), p.1

2023

Link zum Volltext

Verfügbarkeit prüfen

Serum Fibroblast Growth Factor 23 Levels are Associated with Vascular Smooth Muscle Dysfunction in Type 2 Diabetes

Journal of Atherosclerosis and Thrombosis, 2023/12/01, Vol.30(12), pp.1838-1848

2023

Link zum Volltext

Verfügbarkeit prüfen

Positive association between proinsulin and fatty liver index in people with type 2 diabetes

ENDOCRINE JOURNAL, 2024, Vol.71 (2), p.193-197

2024

Link zum Volltext

Verfügbarkeit prüfen

Improvement of β-Cell Function After Switching From DPP-4 Inhibitors to Oral Semaglutide: SWITCH-SEMA2 Post Hoc Analysis

The journal of clinical endocrinology and metabolism, 2024-05

2024

Link zum Volltext

Verfügbarkeit prüfen

Clostridium butyricum-induced ω-3 fatty acid 18-HEPE elicits anti-influenza virus pneumonia effects through interferon-λ upregulation

Cell reports (Cambridge), 2022-12, Vol.41 (11), p.111755-111755, Article 111755

2022

Link zum Volltext

Verfügbarkeit prüfen

Effect of Switching to Once-Weekly Semaglutide on Non-Alcoholic Fatty Liver Disease: The SWITCH-SEMA 1 Subanalysis

Pharmaceutics, 2023-08, Vol.15 (8), p.2163

2023

Link zum Volltext

Verfügbarkeit prüfen

Inverse association between glucose variability and body fat in type 2 diabetes with impaired endogenous insulin secretion assessed using continuous glucose monitoring: A prospective observational study

Diabetes, obesity & metabolism, 2023-07, Vol.25 (7), p.1883-1889

2023

Link zum Volltext

Verfügbarkeit prüfen

descSPIM: an affordable and easy-to-build light-sheet microscope optimized for tissue clearing techniques

Nature communications, 2024-06, Vol.15 (1), p.4941-19, Article 4941

2024

Link zum Volltext

Verfügbarkeit prüfen

Imaging Mass Spectrometry Reveals the Changes in the Taurine Conjugates of Dihydroxycholanoic Acid During Hepatic Warm Ischemia and Reperfusion in a Rat Model

Transplantation proceedings, 2020-07, Vol.52 (6), p.1880-1883

2020

Link zum Volltext

Verfügbarkeit prüfen

Improvement of glycaemic control and treatment satisfaction by switching from liraglutide or dulaglutide to subcutaneous semaglutide in patients with type 2 diabetes: A multicentre, prospective, randomized, open‐label, parallel‐group comparison study (SWITCH‐SEMA 1 study)

Diabetes, obesity & metabolism, 2023-06, Vol.25 (6), p.1503-1511

2023

Link zum Volltext

Verfügbarkeit prüfen

Positive association between proinsulin and fatty liver index in people with type 2 diabetes

Endocrine Journal, 2023, pp.EJ23-0403

2023

Link zum Volltext

Verfügbarkeit prüfen

Glycaemic control efficacy of switching from dipeptidyl peptidase‐4 inhibitors to oral semaglutide in subjects with type 2 diabetes: A multicentre, prospective, randomized, open‐label, parallel‐group comparison study (SWITCH‐SEMA 2 study)

Diabetes, obesity & metabolism, 2024-03, Vol.26 (3), p.961-970

2024

Link zum Volltext

Verfügbarkeit prüfen

Switching from Insulin Degludec plus Dipeptidyl Peptidase-4 Inhibitor to Insulin Degludec/Liraglutide Improves Glycemic Variability in Patients with Type 2 Diabetes: A Preliminary Prospective Observation Study

Journal of Diabetes Research, 2022-01, Vol.2022, p.5603864-9

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 65

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(51)
Mit Volltextzugriff
(65)

Publikationsform

Sprache

Englisch
(55)
Japanisch
(21)

Erscheinungsjahr

n.n

Thema

Science & Technology
(38)
Life Sciences & Biomedicine
(34)
Humans
(23)
Endocrinology & Metabolism
(15)
Diabetes
(11)
Female
(11)
Male
(10)
Adult
(9)
Diabetes Mellitus
(9)
Type 2 Diabetes
(8)
Insulin
(6)
Middle Aged
(6)
Antidiabetics
(5)
Pharmacology & Pharmacy
(5)
Type 1 Diabetes
(5)
Aged
(4)
Animals
(4)
Covid-19
(4)
Diabetes Mellitus, Type 2 - Drug Therapy
(4)
Fibroblast Growth Factor 23
(4)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Can ChatGPT Correct Code Based on Logical Steps?

Is neural machine translation approach accurate enough for coding assistance?

New-onset Type 1 Diabetes after COVID-19 mRNA Vaccination

New‐onset fulminant type 1 diabetes after severe acute respiratory syndrome coronavirus 2 vaccination: A case report

Positive association between proinsulin and fatty liver index in people with type 2 diabetes

Regulation of c‐MYC transcriptional activity by transforming growth factor‐beta 1‐stimulated clone 22

A chemogenetic platform for controlling plasma membrane signaling and synthetic signal oscillation

History of the G Protein–Coupled Receptor (GPCR) Assays From Traditional to a State-of-the-Art Biosensor Assay

Dynamic changes in endoplasmic reticulum morphology and its contact with the plasma membrane in motor neurons in response to nerve injury

Role of adiponectin in the relationship between visceral adiposity and fibroblast growth factor 23 in non-diabetic men with normal kidney function

Successful management of a patient with active Cushing’s disease complicated with coronavirus disease 2019 (COVID-19) pneumonia

Do the benefits of sodium-glucose cotransporter 2 inhibitors exceed the risks in patients with type 1 diabetes?

786-P: Effects of Switching from Liraglutide or Dulaglutide to Subcutaneous Semaglutide on Metabolic Parameters in Older People with Type 2 Diabetes Mellitus—SWITCH-SEMA1 Subgroup Analysis

Serum Fibroblast Growth Factor 23 Levels are Associated with Vascular Smooth Muscle Dysfunction in Type 2 Diabetes

Positive association between proinsulin and fatty liver index in people with type 2 diabetes

Improvement of β-Cell Function After Switching From DPP-4 Inhibitors to Oral Semaglutide: SWITCH-SEMA2 Post Hoc Analysis

Clostridium butyricum-induced ω-3 fatty acid 18-HEPE elicits anti-influenza virus pneumonia effects through interferon-λ upregulation

Effect of Switching to Once-Weekly Semaglutide on Non-Alcoholic Fatty Liver Disease: The SWITCH-SEMA 1 Subanalysis

Inverse association between glucose variability and body fat in type 2 diabetes with impaired endogenous insulin secretion assessed using continuous glucose monitoring: A prospective observational study

descSPIM: an affordable and easy-to-build light-sheet microscope optimized for tissue clearing techniques

Imaging Mass Spectrometry Reveals the Changes in the Taurine Conjugates of Dihydroxycholanoic Acid During Hepatic Warm Ischemia and Reperfusion in a Rat Model

Improvement of glycaemic control and treatment satisfaction by switching from liraglutide or dulaglutide to subcutaneous semaglutide in patients with type 2 diabetes: A multicentre, prospective, randomized, open‐label, parallel‐group comparison study (SWITCH‐SEMA 1 study)

Positive association between proinsulin and fatty liver index in people with type 2 diabetes

Glycaemic control efficacy of switching from dipeptidyl peptidase‐4 inhibitors to oral semaglutide in subjects with type 2 diabetes: A multicentre, prospective, randomized, open‐label, parallel‐group comparison study (SWITCH‐SEMA 2 study)

Switching from Insulin Degludec plus Dipeptidyl Peptidase-4 Inhibitor to Insulin Degludec/Liraglutide Improves Glycemic Variability in Patients with Type 2 Diabetes: A Preliminary Prospective Observation Study

Suchergebnisse filtern